Abstract

The Islamic (lunar) calendar has 11 fewer days each year than the Gregorian (solar) calendar. Consequently, ambient temperatures during the month of Ramadan and the duration of the presunrise-to-sunset fast will change each year. At some point, individuals observing Ramadan will experience prolonged periods of fasting during the hot summer months. In this manuscript, findings published in the English-language medical literature that address the impact of prolonged fasting during the warmer summer months on patients with chronic kidney disease, including dialysis and transplantation patients, are reviewed. This is of particular concern given the accelerated pace of global warming. The limitations of the evidence that is currently available are also discussed, and an approach that might be used to standardize future evaluations of the impact of fasting on kidney health is suggested.

1. Introduction

The Islamic year is defined by a lunar calendar and includes 354 days and is thus 11 days shorter than the Gregorian calendar year. Therefore, the month of Ramadan begins 11 days earlier each year relative to the Gregorian calendar and occurs in a completely different season every nine years (i.e., a full rotation through all four seasons every 33 years). Consequently, the daily duration of the fast and ambient temperatures during the month of Ramadan changes not only according to geographic location but also over time. This seasonal shift may require participants to experience prolonged fasting during the hot summer months.

2. The Significance of Fasting Duration

Muslims worldwide are expected to follow the sunrise and sunset times at their location to mark the beginning and end of the daily Ramadan fast. This requirement is maintained even during the summer, when the daily fast may exceed 16 hours in the northernmost regions. However, if prolonged daily fasting makes it difficult to perform one’s job or may harm one’s health, it is permissible to break the fast and resume it at any time before the next Ramadan by fasting for the same number of days as those missed [1, 2]. Some scholars, however, have suggested that Muslims residing in locations that would require fasting for more than 20 hours might begin their daily fast according to local sunrise time and fast for the same number of hours as would be required of those currently living in Mecca; in other words, individuals in these extreme geographical locations might cease fasting even if sunset has yet to occur [3]. This duration variability is one of the confounding variables that precludes an accurate assessment of the effects of Ramadan fasting on health-related biomarkers [4]. Long fasting duration may have an indirect effect on kidney health, including disruptions of sleep and circadian rhythm because of the sudden shifts in meal times and disruption of the timing and frequency of medications [5, 6].

3. The Significance of a Hot Ambient Temperature

3.1. Heat Stress

Heat stress is the sum of the heat generated by the body (e.g., clothing and physical activities) and the heat generated by the environment (e.g., air temperature, radiant temperature, humidity, and air velocity), minus heat lost from the body to the environment through dry and evaporative loss (e.g., perspiration) [710]. It is influenced by age, sex, body surface area, body mass index (BMI), heat/exercise acclimatization, preexisting comorbidities (e.g., cardiovascular disease (CVD), diabetes mellitus (DM)), alcohol intake, medications (antipsychotics, sedatives, diuretics, laxatives, anticholinergics, beta-blockers, calcium channel blockers), and hydration status [710]. It is also influenced by occupational heat gain from working in hot weather (e.g., agricultural work during the summer, working near furnaces and boilers), physical activity (e.g., construction), protective clothing (e.g., firefighting), [11, 12], and housing conditions (e.g., homes with poor ventilation and no air conditioning) [9]. Heat stress that overwhelms the physiological thermoregulatory compensatory mechanisms can elevate core body temperature (i.e., heat strain) and lead to heat-related illnesses (HRIs) that can be categorized as minor (e.g., edema, cramps, rash), mild (e.g., heat syncope), moderate (e.g., heat exhaustion), or severe (e.g., heat stroke with or without multiorgan failure) [9]. Wet bulb globe temperature (WBGT) is frequently used to predict the likelihood of HRI. This tool measures heat stress in direct sunlight and takes into account temperature, humidity, wind speed, sun angle, and cloud cover (i.e., solar radiation) [13]. A WBGT measurement above 32.0°C indicates a high risk of HRI among those with physically demanding outdoor jobs as well as patients in vulnerable groups [14].

3.2. Global Warming, the Kidney, and Ramadan fasting

The climate is warming at an unprecedented rate, as the global surface temperature was 1.09°C higher in 2011–2020 than in 1850–1900. As a consequence, heat extremes are increasing in frequency, duration, and intensity [15]. Temperature is rising in all parts of the world, especially the tropics and the Middle East-North Africa (MENA) regions, where most of the Muslim majority countries are. These regions are already warm and dry, and now, with global warming, they are becoming worse. A rise in temperature above 2°C will also increase the risk of floods, wildfires, and draught [1620]. Global warming will definitely increase the risks of HRIs and impact kidney health while fasting Ramadan during the long, hot summer months as a result of the increased incidence of serious kidney-related problems brought about by global warming. These problems include heat-induced fluid loss from perspiration, which can lead to reduced urine volumes and increased urine supersaturation of stone-forming salts [2123] in susceptible individuals, most notably those presenting with predisposing genetics and socioeconomic factors (i.e., diet, area of residency, occupation, and exposure to sunlight) [24]. This fluid loss is not replaced while fasting, compounding the situation. It also includes acute kidney injury (AKI), which can result from rhabdomyolysis induced by extreme heat exposure and/or from hypovolemia [2123]. Recurrent episodes of AKI can lead to chronic kidney disease (CKD) and eventually kidney failure. Furthermore, patients with CKD are at increased risk of future episodes of AKI [2528]. Global warming is projected to cause floods that disrupt water treatment facilities, thereby reducing water supply and resulting in water contamination [29]. Water contamination will increase the prevalence of water- and vector-borne diarrheal diseases associated with poor hygiene and sanitation in low- and middle-income countries (LMICs) and lead to dehydration, hypovolemia, and AKI [23, 30]. At the same time, prevention strategies designed to prevent vector-borne diseases are frequently cost-prohibitive in these locations [23]. This is highly relevant given the possibility that Ramadan fasting in extremely hot weather for long hours may increase the risk of AKI in CKD patients, and rising temperatures and water shortages will only make the situation worse, especially in LMICs where infrastructure for early detection and management of AKI is already limited. A rise in the incidence of recurrent urinary tract infections with reduced urine volume, especially in people with poor hydration habits and poor hygiene, is another expected problem with global warming [22, 23, 25]. In addition, global warming could further increase the prevalence of CKD of unknown etiology or chronic interstitial nephritis in agricultural communities (CINAC), which is a condition that primarily affects agricultural workers in warmer LMICs, that may result in part from recurrent and persistent exposure to occupational heat stress and dehydration, which is exacerbated by prolonged fasting in hot weather [2123].

4. Impact of the Duration of Fasting and Hot Ambient Temperatures on Kidney Health

4.1. Any Evidence?

Full papers on Ramadan and kidney health published in English-language databases listed in PubMed, Scopus, Web of Science, and Google Scholar databases that focused on the impact of Ramadan on kidney health were reviewed for evidence of the impact of prolonged fasting and high ambient temperatures on patients with kidney disease. Fasting duration for the date (when reported) and location of each study was obtained from reference [31], and ambient temperature during Ramadan at the time each study was performed was obtained from references [32, 33]. The studies reviewed were divided into four groups, including patients with or without kidney disease, nephrolithiasis, dialysis patients, and kidney transplant recipients. Methods and outcomes are summarized in Tables 14 and Tables 58, respectively.

4.1.1. Impact of Fasting on Kidney Function in Study Subjects with or without Nondialysis (ND) CKD

Twenty-five studies that addressed kidney function in these patient cohorts were identified and of these studies, only one was a multicenter study, two were retrospective, and one failed to report the statistical analysis method used. Two of the 25 studies were conducted during the winter months, 21 were conducted during the summer, and one did not report the date of the study. The methods used and outcomes from these studies are summarized in Tables 1 and 5, respectively.

One of the aforementioned retrospective studies was conducted in Turkey and compared fasting CKD patients who developed AKI during the months of Ramadan in 2013 and 2014 to fasting CKD patients who did not develop AKI. While high blood pressure (BP) and the number of days that each study participant fasted were significant risk factors for AKI, treatment with renin-angiotensin-aldosterone system inhibitors (RAASi) was not. CKD patients who developed AKI tended to be older with higher baseline levels of creatinine and proteinuria. Study participants were evaluated only during Ramadan; no estimated glomerular filtration rate (eGFR) values were provided before, during, or after this month [34].

The second retrospective study was performed in the Kingdom of Saudi Arabia (KSA), where the authors attempted to determine the incidence of AKI during the months of Ramadan (assuming the likelihood of fasting) compared to Shawal (the following month) in 2016 and 2017. The results revealed a statistically significant higher incidence of AKI during Shawal, with high BP, a history of AKI, and concomitant cirrhosis as significant predictors. The authors concluded that the higher incidence of AKI might be attributed to higher ambient temperatures in Shawal than in Ramadan during the years included in this study [35].

Three prospective studies that did not include nonfasting control groups evaluated the development of worsening kidney function (WKF) and AKI. Results from a study conducted in Morocco revealed that 12% of the participants developed AKI (one at Stage 1–2, five at Stage 3, and one at Stage 4). Five participants recovered completely while two recovered only partially. No specific risk factors were identified except for a baseline creatinine clearance (Cr Cl) <60 mL/min. While the average baseline (pre-Ramadan) Cr Cl for all study participants was 72.9 mL/min, Cr Cl values during and after Ramadan were not reported [36]. Another prospective study that was conducted in Turkey evaluated the incidence of AKI Stage 2 just before Iftar (the postsunset meal). The results of this study revealed a small (5 μmol/L) but statistically significant increase in mean creatinine levels just before Iftar that did not meet acute kidney injury network (AKIN) criteria (i.e., thirst period <48 hours long and creatinine increase <26.5 μmol/L) [37]. The third study from the KSA evaluated fasting CKD-ND (Stages 3–5) and reported WKF in 34% of the 36 participants, including 15 during and seven after Ramadan, with 7/36, 12/24, and 3/5 with stages 3, 4, and 5 disease, respectively. Of note, eight participants improved. Lower baseline eGFR, higher baseline systolic BP, and younger age were reported as risk factors for WKF. There was no effect on serum potassium. However, no Ramadan or post-Ramadan eGFR values were provided [38]. One undated study without a control group reported a significant decline in Cr Cl from pre-Ramadan baseline of 17.2 mL/min during Ramadan that persisted for two weeks [39].

One study performed in Egypt that was conducted during the winter used technetium (Tc)-99m stannous diethylene-triamine-pentaacetate (DTPA) renography to measure GFR before and during Ramadan in patients with CKD. While they observed no significant changes in GFR, the authors reported a small increase in urinary N-acetyl-beta-D-glucosaminidase (NAG), suggesting renal tubular injury, and significantly higher potassium levels during Ramadan [40]. A study conducted in the United Arab Emirates (UAE) included estimated Cr Cl values collected before, during the final week, and one month after Ramadan. Among their findings, the authors reported statistically significant improvements in eGFR during and after Ramadan, with no risk of hyperkalemia and no changes in the urine protein-creatinine ratio (PCR) [41]. However, a study focused on fasting diabetics in Egypt conducted during the summer reported a significant increase in urinary albumin-creatinine ratios (ACRs) from baseline but did not discuss kidney function [42].

The search identified six prospective studies that were conducted in the summer that included nonfasting control groups. The results of one prospective study from Turkey that focused on patients with polycystic kidney disease (PCKD) revealed no significant changes in eGFR, potassium levels, 24-hour urine volumes, or urine biomarkers. However, the authors did report significant reductions in proteinuria in the fasting group [43]. Another study from Egypt reported a decline in eGFR during Ramadan, especially among patients treated with RAASi and diuretics; the authors also noted an increased risk of cardiovascular (CV) events in patients with preexisting CV disease (CVD) and early increases in creatinine levels. Interestingly, creatinine levels were not significantly different from those reported at baseline three months after Ramadan [44]. Results from a third study conducted in Turkey revealed no significant changes in pre- and post-Ramadan eGFR measurements between the two groups with a trend towards improved eGFRs among those who were fasting. Of note, the four patients in each group that experienced WKF were older and undergoing treatment with diuretics [45]. Another study conducted in Turkey revealed that although 12.5% of fasting and 7.5% of nonfasting patients developed WKF, this difference did not achieve statistical significance. However, the authors reported that DM and proteinuria were both risk factors for WKF [46]. The authors of a study from the United Kingdom (UK) reported no significant changes when comparing pre and postRamadan creatinine levels, PCRs, weight, or BP either within or between the two groups, and no episodes of AKI [47]. Results from the final study in this group conducted in Turkey reported a small but statistically significant increase in eGFR among patients in the fasting group and a decline in eGFR among those who were not fasting, with no effects on ACR or potassium levels [48].

The remaining prospective, uncontrolled studies evaluated changes in eGFR or Cr Cl. The authors of one study conducted in the UAE reported no significant changes in eGFR, weight, BP, or potassium levels [49]. Similarly, results from a study conducted in Egypt revealed significant changes in creatinine levels, weight, BMI, muscle and bone mass, total body water, and visceral fat using electrical bioimpedance after Ramadan fasting, accompanied by an insignificant rise in eGFR [50]. Similarly, results from a study conducted in India revealed no significant differences in mean creatinine and eGFR before versus after Ramadan fasting. Four patients with CKD-ND (Stages 4–5) exhibited WKF; two of these patients improved after Ramadan while two did not. Low eGFR was the only risk factor associated with WKF [51]. One study conducted in Egypt split fasting diabetics into three groups: Group 1, ACR >30 and 60 mL/min/1.73 m2 < eGFR <90 mL/min/1.73 m2; Group 2, ACR >30 and eGFR >90 mL/min/1.73 m2; and Group 3, no CKD. ACR increased and eGFR decreased significantly from pre-Ramadan to post-Ramadan in groups 2 and 3 but not in group 1 [52]. Another study from Egypt revealed a small but statistically significant increase in mean creatinine and mean urine ACR after Ramadan; no eGFR values were reported [53]. The results of a study conducted in Singapore revealed statistically significant reductions in weight, BP, and eGFR during Ramadan from values obtained at baseline. Increases in serum potassium levels observed during Ramadan correlated with reductions in eGFR reduction but not with RAASi use [54]. Similarly, a study from Pakistan reported a significant decline in the mean eGFR six weeks after Ramadan. However, there were no changes in the mean eGFR in the 29 patients with a mean baseline eGFR of 72 mL/min/1.73 m2 who presented for follow-up at 12 months. The number of patients in this study with eGFRs <60 mL/min/1.73 m2 was not reported; however, reductions in eGFR were the same in both CKD and nonCKD patients [55]. A study from Morocco reported a significant decline in eGFR together with an increase in hydration (as measured by bioimpedance) and a 67% increase in creatinine levels. While the risk of AKI was significantly higher in patients with an eGFR <60 mL/min/1.73 m2, it is not clear how many of the patients enrolled in this study were in this category. The authors did not comment on any changes in the ACR [56]. Another study from Egypt reported a significant increase in Cr Cl during Ramadan among nondiabetic patients on vitamin E. All patients also experienced nonsignificant reductions in ACR; precise values for Cr and Cl were not reported [57]. A prospective study from KSA that evaluated patients with CKD-ND (Stages 3–5) reported no significant changes in eGFR, urine volume, or proteinuria [58].

4.1.2. Risk of Nephrolithiasis with Fasting

Of the eight studies reviewed on this topic (four prospective and four retrospective), none reported eGFR. Two multicenter and three retrospective studies compared the incidence of nephrolithiasis during Ramadan to that reported for other months. Three of the studies took place during the summer, two were conducted during the cooler months, and one evaluated the incidence of nephrolithiasis in the summer compared to the winter. Three of the studies (two prospective and one retrospective) recruited males only. None of the retrospective studies confirmed fasting status. The methods used and outcomes from these studies are summarized in Tables 2 and 6, respectively.

Two prospective studies reported the results of a urinalysis only; both of these studies recruited males only and did not report dates. While one study reported no significant reductions in urine volume [59], another highlighted significant reductions in urine volume during Ramadan with no increased risk of calculus formation [60].

The six remaining studies reported the incidence of renal colic in Ramadan compared to all other months. A retrospective study from KSA compared the incidence of renal colic during Ramadan in winter versus summer as well as in non-Ramadan summer and winter months over a five-year period. The findings revealed that Ramadan fasting did not increase the risk of urinary calculi. This was the only study in which nephrolithiasis was confirmed with a computed tomography scan [61]. A prospective study from Iran conducted during the summer reported a higher incidence of renal colic during the first two weeks of Ramadan compared to periods before, during the last two weeks during, or after Ramadan. The authors concluded that ambient temperature did not contribute to these findings [62]. A retrospective study from Bahrain reported a higher incidence of renal colic during Ramadan and the month thereafter than during the preceding month. Unfortunately, the effects of ambient temperature were not evaluated [63]. The other two studies reported a higher incidence of renal colic in warmer months and no increased incidence in Ramadan; however, Ramadan was observed during the cooler months at that time [64, 65]. A prospective study from Pakistan reported s similar incidence of renal colic during Ramadan and the following month (Shawal), despite the warmer weather experienced during Ramadan [66].

4.1.3. Ramadan Fasting and Dialysis

There were nine studies (eight prospective and four multicenter) that focused on Ramadan fasting by hemodialysis (HD) patients. The methods used and outcomes from these studies are summarized in Tables 3 and 7, respectively. One retrospective single-center study considered HD-associated mortality over 24 years (19892012). Among their findings, deaths were most frequent (with respect to the Gregorian calendar) in December and January (i.e., the cooler months in the Northern Hemisphere). Similarly, the largest number of deaths with respect to the Islamic calendar took place during Ramadan, which was observed in the cooler months during most of the study period; this effect was not observed in the preceding (Shaban) or the following (Shawal) months. The authors suggested that changes in dietary habits were a contributing factor to the overall higher rate of mortality during Ramadan. The fasting status of the deceased patients was not reported [67].

Four of the prospective studies included a nonfasting control group, and three were conducted during the summer months [6870]. One was a multicenter study that evaluated patients before and during Ramadan but did not report the statistical analysis method used. This study reported no significant changes in interdialytic weight gain (IDWG), BP, or potassium levels, but did note an increased number of missing sessions among those in the fasting group [68]. The other two studies compared the outcome of daily fasting to fasting on-and-off HD days and no fasting whatsoever. A single-center study conducted in Palestine evaluated patients before, during, and after Ramadan and reported higher IDWG and potassium levels among those in the daily fasting group and only slightly higher IDWG for the partial fasting group, most notably among the patients diagnosed with diabetes [69]. By contrast, an Egyptian multicenter study evaluated patients before and after Ramadan only and reported small but statistically significant reductions in BP overall and changes in potassium levels in two of the groups. No changes in the urea reduction ratio were observed among members of the fasting group, and IDWG was not reported [70]. Another single-center prospective study that did not include dates reported no increase in IDWG or potassium levels [71]. Three additional prospective studies had no nonfasting control groups and were also conducted during the summer.

Two multicenter studies from Malaysia were reviewed. The first reported no change in dry weight, IDWG, BP, or potassium levels when comparing pre-Ramadan values to those measured at the end of Ramadan [72]. The second study combined patients who were fasting more than 20 days and those fasting fewer than 20 days (22% partial) and reported significant reductions in IDWG in regular fasting patients (especially among the females) and significant (albeit small) increases in potassium and decreases in phosphorus levels [73]. In addition, one single-center study from KSA that evaluated patients before, during, and after Ramadan reported no change in Kt/V, IDWG, BP, or potassium, despite significant reductions in the duration of each HD session [58]. A prospective single-center study from KSA that did not report the date of study or the sex of subjects evaluated patients before and during Ramadan and reported small but significant increases in IDWG and potassium levels; however, none of these changes led to visits to the emergency department [74].

Only one study assessed the feasibility of Ramadan fasting for patients maintained on peritoneal dialysis (PD) [75]. This was a comparatively small (18 patients only), single-center, prospective study conducted at the end of the summer (average temperature of 35°C and average fasting duration of 14 hours) with no nonfasting control group. The treatment schedules for both continuous ambulatory peritoneal dialysis (CAPD) and continuous cycler peritoneal dialysis (CCPD) were modified to avoid exchanges during fasting hours. Patients were evaluated pre-Ramadan, every two weeks during Ramadan, and four weeks post-Ramadan. Occupations and physical activity were not reported. Although three patients had to break their fasts, the results revealed no significant change in Cr Cl, Kt/V, or urine output between pre- and post-Ramadan values.

4.1.4. Impact of Fasting on Kidney Transplant Recipients

Twelve studies that focused on the impact of Ramadan fasting on kidney transplant recipients were identified. All but one of these studies were prospective in nature, and all but one were performed at a single center. All 12 studies collected pre-, during-, and post-Ramadan values, and six of these studies included a nonfasting control group. Two studies did not report the statistical analysis methods used [76, 77], and another did not report the date of the study [78]. Only two studies were conducted during the warmer months. The methods used and outcomes from these studies are summarized in Tables 4 and 8, respectively. Overall, and despite differences in baseline values, these studies reported no statistically significant change in eGFR [79, 80]. The studies that were conducted in the cooler months were all prospective and included three from KSA: two without a control group [81, 82] and one with a control group; [83] one from Algeria without a control group; [84] one from Kuwait with a control group and was the largest; [85] one from UAE without a control group; [86] and one from Iran with a matched control group [87]. All these studies showed that fasting in cooler months was safe for kidney transplant recipients. There was also a meta-analysis of eight studies that evaluated the overall impact of Ramadan fasting on kidney transplant recipients between 1999 and 2019 and included 549 patients from five Middle East/North Africa (MENA) countries. Only two of the studies included in this meta-analysis were conducted during the summer; both of these studies included a nonfasting control group. Results from five studies with 442 fasting patients that served as their own controls revealed no significant changes in eGFR after Ramadan. While three studies that used nonfasting patients as controls reported a significant decline in eGFR, the authors of the meta-analysis noted that this finding was associated with significant publication bias [88].

5. Limitations of the Current Medical Literature

The evidence extracted from the aforementioned reviewed studies is limited and provides no specific guidelines or recommendations for Ramadan fasting in individuals living with kidney diseases for a variety of reasons. Given the obligatory nature of Ramadan fasting, it is not possible to perform randomized-controlled interventional trials. Individuals who have been deemed fit to fast must do so and cannot be randomized to a nonfasting group. Thus, all published studies on Ramadan fasting are by their nature noninterventional and observational. While most of these studies were prospective, several were retrospective, and most were small and performed at a single center. In addition, most studies had the fasting subjects serving as their own controls, and only a few studies had a nonfasting control group. Some studies evaluated the incidence of AKI during Ramadan compared to other months; however, this is not a true nonfasting control group not only because of the different dates and weather conditions but also because of the daily rituals and other dietary habits associated with Ramadan no longer being followed. The mean age of participants was <60 years in all of the kidney transplant and nephrolithiasis studies. Only one hemodialysis (HD) study and eight of the 25 studies that compared healthy and CKD patients featured a mean age of 60 years or more. While some studies assessed changes in eGFR from a measured baseline, others compared the incidence of WKF or AKI using the Kidney Disease: Improving Global Outcome (KDIGO) definition of the latter condition [89]. Studies used different methods to calculate eGFR [90, 91]. Some used the chronic kidney disease-epidemiology collaboration formula (CKD-Epi) or the modification of diet in renal disease formula (MDRD). Similarly, while some studies used the Cockcroft-Gault (CG) formula to determine Cr Cl, others only measured creatinine levels. One study evaluated renal function using a DTPA scan [40]. Different methods were used to assess the impact of Ramadan fasting on patients with kidney disease. Some assessed variables pre-, during-, and post-Ramadan, while others focused on pre- and during Ramadan or during- and post-Ramadan only. The timing of the post-Ramadan observations also differed between studies. Studies designed to evaluate Ramadan fasting in HD patients focused either on changes in Kt/V or IDWG. It is also important to point out that it is difficult to obtain blood samples from fasting HD patients before Iftar. Most of these patients can be evaluated only after Iftar, when they present for an HD session. The Iftar meal would certainly alter the blood biochemistry profile, patient weight, and BP measurements obtained. Although all studies aimed to assess the impact of fasting for the entire month of Ramadan, there are frequently numerous interruptions (for traveling, acute illness, or menstruation). Thus, many individuals do not fast for the entire month. This may have a profound influence on the outcomes of these studies. The number of missed days was reported differently in each study (e.g., partial or complete fast, fasting >25 days or <20 days, and so on), and many did not report when the interruption occurred (i.e., in early, middle, or late Ramadan). Some HD studies reported that participants fasted only on non-HD days. Many of the CKD studies suffered from poor patient adherence to scheduled follow-up appointments. Some studies excluded CKD patients who were deemed unfit to fast. However, it was not clear whether or not these excluded patients actually fasted. If they did, the outcomes should have been reported as real-life evidence. It is also important to mention that there is only one single-center prospective study on the outcomes of Ramadan fasting among patients undergoing PD [75].

5.1. Disparity of Results from Published Literature

The considerable disparity in results obtained in studies with similar methods and objectives is the result of a variety of reasons that includes differences in the timing of Ramadan and the study location. These factors will, by their nature, have a profound impact on ambient temperature, humidity, and the duration of the day-long fast. The temperature and fasting duration can differ dramatically depending on whether Ramadan falls in the summer or the winter in a given location and year. These factors may have an impact on dietary intake, meal frequency, and physical activity. Countries situated near the equator experience no significant temperature variability between months. Of note, some studies did not report the year in which the study was conducted. It also includes differences in the timing of the blood sampling during fasting hours. Timing can vary from early morning to just before Iftar and might even be performed after Iftar in the case of HD patients. Some studies did not report the timing of blood collection. Most of the studies also lacked accurate data on subjects’ dietary habits, physical activity, occupation, and/or exposure to weather. One or more of these variables may influence the outcome of the Ramadan fast. For example, several Islamic countries, including the KSA, UAE, Kuwait, and Qatar, have instituted changes to working hours during the month of Ramadan. Many of the retrospective studies assumed that the recruited subjects were fasting during Ramadan. Another important factor is air-conditioning. while air conditioning is widely available in the Arabian Gulf states, this is not the case in many other parts of the world. This may alter the duration of exposure to hot weather and hence the degree of volume loss, particularly during the warmest summer months.

5.2. Suggested Standards for Data Reporting

Researchers in this field need to develop a universally accepted definition of high average temperature (e.g., above 35°C) and prolonged fasting duration (e.g., more than 16 hours). All reports on the impact of fasting during Ramadan need to include the location, the dates of study, the average temperature during the study days, the average fasting duration, the number of days fasting, and the statistical methods used to evaluate the findings. They should also include participant age, sex, occupation (e.g., outdoor versus indoor, physical versus sedentary work), living conditions (e.g., living alone or in a group/family setting), type of diet, and availability of air conditioning. Medications, particularly the frequency of diuretic use and adherence to amounts prescribed, should be reported. It is desirable to have a control group of individuals who are not fasting during Ramadan. Changes in eGFR should be calculated using the CKD-Epi formula as suggested by KDIGO [92] using pre-Ramadan, Ramadan, and post-Ramadan values. Timing for the pre- and postvalues should also be standardized (for example, four weeks before and four weeks after the fast). AKI should be diagnosed as per the KDIGO definition and staged based on pre-Ramadan, Ramadan, and post-Ramadan values. The timing for the pre- and postvalues should be standardized, as noted above. Assessments of HD patients should include changes in mean IDWG and mean Kt/V from pre-Ramadan values. Patients may be instructed to weigh themselves at home before mealtime to determine accurate values for IDWG. Changes in BP or signs of postural hypotension, weight gain, lower limb edema, and/or dyspnea from pre-Ramadan findings should be noted throughout the study period. Symptoms such as lethargy, anorexia, nausea, or headache that suggest electrolyte disturbances or WKF should be reported. The standardization of medical research on Ramadan fasting was originally suggested in 2015. Unfortunately, this has not yet been fully embraced by researchers in the field [93].

6. Conclusions

Ramadan fasting during the prolonged daylight hours and high ambient temperatures experienced during the summer months might be expected to be harmful to the health of patients with kidney disease. Unfortunately, the literature on this subject remains limited, because of the reasons discussed above and provides no clear insight on this subject. Thus, it is difficult to evaluate the individual effects of each of these two variables, particularly in patients with eGFRs <45 mL/min/1.73 m2, in patients older than 65 years of age, and when participants’ occupations and exposures to the environment have not been considered. The Muslim community as a whole would benefit from larger studies (e.g., multicenter and multinational) that use standardized methods similar to those suggested above. While Ramadan will be observed during the winter and early spring months in the Northern Hemisphere during the next few years, these issues will reemerge once it is once again observed during the summer, particularly given the predictions for future worsening global warming.

Data Availability

Previously published studies were used to support this review. These prior studies (and datasets) are cited at relevant places within the text as references [3487].

Conflicts of Interest

The authors declare that there are no conflicts of interest.